CGTX
Cognition Therapeutics
$0.74
−$0.01 (−1.34%)Oct 29, 2026
Key metrics
The numbers that frame CGTX today
- Market cap
- $70.27M
- ROIC
- 1,019.4%
- Div yield
- 0%
- Debt / equity
- 0.0
- 52wk Low
- $0.55
- 52wk High
- $1.83
Growth
Revenue and earnings trend for CGTX
RevenueNet income
See the full growth breakdown
Revenue and earnings trends, margins and the multi-year trajectory - free with an account.
Create a free accountFree foreverNo card required
Already a member? Log inCash flow & returns
Free cash flow and financial health
Free cash flowNet debt
See the full cash-flow picture
Free cash flow detail, returns on capital and the balance-sheet trend - free with an account.
Create a free accountFree foreverNo card required
Already a member? Log inInsider trading
Recent insider buying and selling activity
PurchasesSales
Unlock every insider trade
See who is buying and selling, how much, and when - updated as new filings land.
Create a free accountFree foreverNo card required
Already a member? Log inFrequently asked questions
Plain-English answers about CGTX
Is Cognition Therapeutics a good buy?
No. Cognition Therapeutics has poor quality and poor momentum. Both signals point to a weaker setup. Growth looks excellent, which supports the long-term business case, but that is not enough to offset the weak setup. We think Cognition Therapeutics is selling at a very high price.
What is the market capitalization of CGTX?
Cognition Therapeutics's market capitalization is $70.27M.
What is the 52-week high for CGTX stock?
The 52-week high for Cognition Therapeutics is $1.83. The current close of $0.74 is 59.6% below that high.
What is the 52-week low for CGTX stock?
The 52-week low for Cognition Therapeutics is $0.55. The current close of $0.74 is 34.4% above that low.
Does CGTX stock pay dividends?
Cognition Therapeutics does not currently show a dividend per share in the company data.
What is the Debt / Equity ratio for CGTX?
Cognition Therapeutics's Debt / Equity ratio is 0.02.